MIRA INFORM REPORT

 

 

Report Date :

06.09.2013

 

IDENTIFICATION DETAILS

 

Name :

XL ORTHOMED PRIVATE LIMITED

 

 

Registered Office :

WZ-622D, Shiv Nagar Extension, New Delhi-110058

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

28.07.1992

 

 

Com. Reg. No.:

55-49731

 

 

CIN No.:

[Company Identification No.]

U74899DL1992PTC049731

 

 

IEC No.:

0593045157

 

 

PAN No.:

[Permanent Account No.]

AAACX0056G

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Orthopedic Implants and Instruments.

 

 

No. of Employees :

Information denied by the management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (15)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. The management has not filed the financials of the company with the government departments after 2007. However business is active. Payments are reported to be unknown.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Ranjeet Sharma

Designation :

Business Head Department

Contact No.:

91-11-42851229

91-9136540006

Date :

04.09.2013

 

 

LOCATIONS

 

Registered Office :

WZ-622D, Shiv Nagar Extension, New Delhi-110058, India

Tel. No.:

91-11-42851228/ 42851229

Mobile No.:

91-9871998833 (Mr. Tamanjeet Kochar)

Fax No.:

91-11-42851229/ 42851228

E-Mail :

xlo@rediffmail.com

puneet.matta@gmail.com

radhikamatta@rediffmail.com

Website :

http://www.xlo.in

Area :

5000 sq.ft. (Owned)

 

 

Factory 1 :

Plot No. 8 and 9, Industrial Development Corporation, Sarail Khwaja, Gurukul, Faridabad-121003, Haryana, India

Tel. No.:

91-129-6514989/ 2501183

Fax No.:

91-129-2510173

Area :

Owned

 

 

DIRECTORS

 

AS ON 30.09.2007

 

Name :

Mr. Gurbachan Singh Kochar

Designation :

Director

Address :

G Block, L 13, Hari Nagar, New Delhi-110058, India

Date of Birth/Age :

17.06.1950

Date of Appointment :

28.07.1992

 

 

Name :

Mr. Tamanjeet Kochar

Designation :

Director

Address :

W-40, Greater Kailash Part 1, New Delhi-1210048, India

Date of Birth/Age :

20.09.1984

Qualification :

Diploma in Export Management

Date of Appointment :

01.12.2005

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2007

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Orthopedic Implants and Instruments.

 

 

Products :

Spinal

 

·         Multi Directional Coupling Transverse Rod

·         Transverse Rod Connector

·         Spondylosis Plate

·         Spondylosis Screw

·         Pedicle Screw System

 

Hip

 

·         Bi-Polar Modular Hip System

·         Total Hip Replacement

 

Knee

 

·         Total Knee Replacement

·         Interference Screw

·         Endo-Buttons

 

Nailing

 

·         Short femoral Nail

·         Femoral Nail

·         Tibial Nail

·         Humeral Nail

 

 

GENERAL INFORMATION

 

No. of Employees :

Information denied by the management.

 

 

Bankers :

  • ICICI Bank, Faridabad, Haryana, India
  • Canara Bank, Lajpat Nagar, New Delhi, India

 

 

Facilities :

Secured Loans

31.03.2007

Rs. In Millions

Canara Bank CC A/C

2.503

Canara Bank Term Loan

0.566

TOTAL

3.069

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Singhalmatt and Company

Chartered Accountants

Address :

B-21, Lajpat Nagar Part 1, New Delhi-110024, India

Tel. No.:

91-11-26412946

Mobile No.:

91-9212253491/ 9811711531

E-Mail :

puneetmatta@yahoo.com

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2007

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000

Equity Shares

Rs. 10/- each

Rs. 0.500 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

40000

Equity Shares

Rs. 10/- each

Rs. 0.400 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.400

0.400

0.400

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

1.773

1.706

1.554

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

2.173

2.106

1.954

LOAN FUNDS

 

 

 

1] Secured Loans

3.069

2.761

2.126

2] Unsecured Loans

0.206

0.206

0.291

TOTAL BORROWING

3.275

2.967

2.417

DEFERRED TAX LIABILITIES

0.397

0.371

0.343

 

 

 

 

TOTAL

5.845

5.444

4.714

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

2.811

3.013

3.201

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.036

0.036

0.036

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

1.652

1.867

2.618

 

Sundry Debtors

2.924

2.297

1.495

 

Cash & Bank Balances

0.105

0.030

0.156

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

0.538

0.577

0.672

Total Current Assets

5.219

4.771

4.941

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

1.804

2.050

3.170 

 

Other Current Liabilities

0.417

0.326

 

 

Provisions

0.000

0.000

0.294

Total Current Liabilities

2.221

2.376

3.464

Net Current Assets

2.998

2.395

1.477

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

5.845

5.444

4.714

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2007

31.03.2006

31.03.2005

 

SALES

 

 

 

Income

8.330

7.819

6.654

 

 

Other Income

 

 

 

 

 

TOTAL                                     (A)

8.330

7.819

6.654

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

Administrative Expenses

7.634

7.062

5.916

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                     (B)

7.634

7.062

5.916

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

0.696

0.757

0.738

 

 

 

 

 

Less

INTEREST                                                         (D)

0.334

0.328

0.202

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

0.362

0.429

0.536

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

0.209

0.209

0.327

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

0.153

0.220

0.209

 

 

 

 

 

Less

TAX                                                                  (H)

0.087

0.068

0.103

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

0.066

0.152

0.106

 

 

 

 

 

 

Earnings Per Share (Rs.)

1.65

--

--

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

PAT / Total Income

(%)

0.79

1.94

1.59

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

1.91

2.83

2.57

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.07

0.10

0.11

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

1.51

1.41

1.23

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.35

2.01

1.43

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

PAN of Proprietor/Partner/Director, if available

No

32]

Date of Birth of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES:

 

S. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

90044425

26/10/2004 *

1,000,000.00

BANK OF BARODA

B - 3., CONNAUGHT PLACE, NEW DELHI - 110001, INDIA

-

2

90043577

26/10/2004 *

600,000.00

BANK OF BARODA

B - 3., CONNAUGHT PLACE, NEW DELHI - 110001, INDIA

-

3

90041128

29/01/1996 *

400,000.00

BANK OF BARODA

H - 11., CONNAUGHT CIRCUS, NEW DELHI - 110001, INDIA

-

 

* Date of charge modification

 

 

NOTE:

 

The Register office of the company has been shifted from E-25/B-1, Extension Mohan Co-Operative Industrial Estate, Badarpur, New Delhi-110044, India to present address w.e.f. 28.11.2006.

 

 

Unsecured Loans

31.03.2007

Rs. In Millions

Due to Directors and their firms

S S K Enterprises

0.146

Due to Others

Poonam Chopra

0.060

TOTAL

0.206

 

 

OPERATIONS:

 

The company has posted a turnover of Rs. 8.330 Millions as compared to Rs. 7.819 Millions of previous year. The profit during the year before tax is Rs. 0.153 Million as compared to Rs. 0.220 Million of the previous year.

 

 

FIXED ASSETS:

 

·         Plant and Machinery

·         Mobile Phone

·         Vehicles

·         Generator

·         Furniture and Fixture

·         Cycle

·         Computer

·         Fans and Coolers

·         Pager

·         Time Keeping Watch

·         Factory Building

 

NEWS

 

FDA SEALS FARIDABAD PHARMA UNIT

 

JULY 17, 2013

 

A team of the Food and Drug Administration (FDA), Haryana, on Wednesday raided the premises of a manufacturing unit in Faridabad and sealed it as it was found violating various provisions of the Drugs and Cosmetics Act.

The unit of XL Orthomed (Private) Limited, Sarai Khawaja, Faridabad, was manufacturing sterile and non-sterile orthopaedic implants, which came under the definition of 'drug', which was unlicensed, a spokesperson for the FDA said.

 

The unit was inspected in 2011 by the FDA team along with FDA officials from the Central Drugs Standard Control Organisation during which many shortcomings of serious nature were observed. The state drugs controller, Haryana, had directed the firm to remove them but it didn't mend its ways.

 

The spokesperson said that during the raid, the firm was found manufacturing sterile orthopaedic implants without holding a drug manufacturing licence. The firm had manufactured sterile orthopaedic implants without maintaining the required clean room conditions either, which could be harmful to patients to whom these orthopaedic implants were to be implanted.

 

An orthopaedic implant is a medical device manufactured to replace a missing joint or bone or to support a damaged bone.

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.04

UK Pound

1

Rs.103.11

Euro

1

Rs.86.99

 

 

INFORMATION DETAILS

 

Information Gathered by :

PDT / SVA

 

 

Report Prepared by :

TPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

2

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

1

--LIQUIDITY

1~10

1

--LEVERAGE

1~10

1

--RESERVES

1~10

1

--CREDIT LINES

1~10

1

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

15

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.